Last reviewed · How we verify

NCT05370014

Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads

Recruiting now NA Last updated 16 May 2025
What this trial tests

NA trial testing Integrating Community-based Intervention Under Nurse Guidance with Families (iCINGS FAM) in SARS- CoV-2 in 500 participants. Currently enrolling.

Timeline
3 January 2023
Primary endpoint
30 May 2026
30 June 2026

Quick facts

Lead sponsorUniversity of South Carolina
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment500
Start date3 January 2023
Primary completion30 May 2026
Estimated completion30 June 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of South Carolina

Who can join

18 and older, any sex, with SARS- CoV-2 or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study tests the efficacy of a dyadic intervention to mitigate the adverse health consequences of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2 )(COVID-19) in African American (AA) adults with pre-existing chronic health conditions and their informal carepartners (IC). Socioeconomically disadvantaged, older, and Black/African American from rural regions are burdened with greater rates of chronic diseases such as diabetes, hypertension, chronic kidney disease, cardiovascular disease, and stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of South Carolina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05370014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing